The 39 rating InvestorsObserver gives to Cyclacel Pharmaceuticals Inc (CYCC) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 27 percent of stocks in the Biotechnology industry, CYCC’s 39 overall rating means the stock scores better than 39 percent of all stocks.
CYCC has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on CYCC!